IRADIMED CORP
For the period ended Dec 31, 2024. Filed Mar 6, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 6, 2025
IRMD$86.94+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Operations
| · · · · · | |||
|---|---|---|---|
| | Year Ended | ||
| | December 31, | ||
| · 2024 · 2023 | |||
| Revenue | $73,242,121 | | $65,562,296 |
| Cost of revenue | 16,892,240 | | 15,404,027 |
| Gross profit | 56,349,881 | | 50,158,269 |
| Operating expenses: | | ||
| General and administrative | 15,937,123 | | 15,122,065 |
| Sales and marketing | 15,616,442 | | 12,142,090 |
| Research and development | 2,831,589 | | 2,858,656 |
| Total operating expenses | 34,385,154 | | 30,122,811 |
| Income from operations | 21,964,727 | | 20,035,458 |
| Other income, net | 2,310,732 | | 1,702,798 |
| Income before provision for income taxes | 24,275,459 | | 21,738,256 |
| Provision for income tax expense | 5,041,433 | | 4,545,480 |
| Net income | $19,234,026 | | $17,192,776 |
| Net income per share: | | ||
| Basic | $1.52 | | $1.36 |
| Diluted | $1.50 | | $1.35 |
| Weighted average shares outstanding: | | ||
| Basic | 12,670,216 | | 12,602,948 |
| Diluted | 12,783,558 | | 12,722,530 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.